Clorox Company (The) (CLX) Raised to “Outperform” at Consumer Edge

Consumer Edge upgraded shares of Clorox Company (The) (NYSE:CLX) from a neutral rating to an outperform rating in a research note released on Friday morning, Marketbeat.com reports.

CLX has been the topic of several other reports. Deutsche Bank AG restated a hold rating and issued a $137.00 price objective (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Jefferies Group LLC restated a hold rating and issued a $132.00 price objective on shares of Clorox Company (The) in a research report on Wednesday, November 1st. Zacks Investment Research cut shares of Clorox Company (The) from a hold rating to a sell rating in a research report on Wednesday, October 4th. BMO Capital Markets restated a buy rating and issued a $150.00 price objective on shares of Clorox Company (The) in a research report on Thursday, October 5th. Finally, Royal Bank Of Canada restated a hold rating and issued a $115.00 price objective on shares of Clorox Company (The) in a research report on Sunday, October 8th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus target price of $128.72.

Shares of Clorox Company (NYSE CLX) traded up $1.37 on Friday, hitting $132.05. The stock had a trading volume of 718,800 shares, compared to its average volume of 815,927. Clorox Company has a 12-month low of $111.77 and a 12-month high of $141.76. The company has a market capitalization of $17,200.00, a PE ratio of 23.79, a PEG ratio of 3.60 and a beta of 0.39. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.77 and a current ratio of 1.10.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.41 by $0.05. The firm had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.48 billion. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The company’s revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.36 earnings per share. equities analysts expect that Clorox Company will post 5.58 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This piece was posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be read at https://www.chaffeybreeze.com/2017/11/13/clorox-company-the-clx-raised-to-outperform-at-consumer-edge.html.

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 2.54%. The ex-dividend date of this dividend is Tuesday, October 24th. Clorox Company (The)’s payout ratio is 61.65%.

In related news, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total value of $1,280,798.01. Following the completion of the sale, the senior vice president now owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Dawn C. Willoughby sold 2,158 shares of the firm’s stock in a transaction on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The disclosure for this sale can be found here. Insiders sold 41,293 shares of company stock valued at $5,560,303 in the last ninety days. 1.00% of the stock is currently owned by insiders.

A number of hedge funds have recently made changes to their positions in CLX. FMR LLC lifted its stake in Clorox Company (The) by 8.3% in the first quarter. FMR LLC now owns 105,949 shares of the company’s stock worth $14,285,000 after acquiring an additional 8,088 shares during the period. Renaissance Technologies LLC lifted its stake in Clorox Company (The) by 11.8% in the first quarter. Renaissance Technologies LLC now owns 1,077,700 shares of the company’s stock worth $145,306,000 after acquiring an additional 113,700 shares during the period. BlackRock Inc. lifted its stake in Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after acquiring an additional 9,698,542 shares during the period. KCG Holdings Inc. lifted its stake in Clorox Company (The) by 108.5% in the first quarter. KCG Holdings Inc. now owns 9,048 shares of the company’s stock worth $1,220,000 after acquiring an additional 4,708 shares during the period. Finally, Pinnacle Wealth Management Advisory Group LLC lifted its stake in Clorox Company (The) by 5.9% in the first quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,525 shares of the company’s stock worth $340,000 after acquiring an additional 140 shares during the period. 71.58% of the stock is owned by institutional investors.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply